Related Experiment Video
Updated: May 23, 2026
09:53
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
Modulating Anti-MicroRNA-21 Activity and Specificity Using Oligonucleotide Derivatives and Length Optimization
Andrés Muñoz-Alarcón1, Peter Guterstam, Cristian Romero
1Department of Neurochemistry, Stockholm University, Svante Arrhenius väg 21A, 106 92 Stockholm, Sweden.
ISRN Pharmaceutics
|April 5, 2012
Summary
Chemical modifications and truncations of anti-microRNA oligonucleotides targeting microRNA-21 impact their activity and specificity. Strategic design, including locked or unlocked nucleic acid monomers and backbone modifications, is key for effective therapeutic development.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- MicroRNAs (miRNAs) are crucial regulators of gene expression involved in development and disease.
- Anti-microRNA oligonucleotides (AMOs) are synthetic molecules designed to inhibit miRNA function.
- miRNA-21 is implicated in the pathogenesis of various human diseases, making it a therapeutic target.
Purpose of the Study:
- To investigate the impact of chemical modifications and truncations on the activity and specificity of AMOs targeting miRNA-21.
- To identify optimal design strategies for developing potent and selective AMOs.
Main Methods:
- Synthesis and testing of various AMO designs, including those with locked nucleic acid (LNA) and unlocked nucleic acid (UNA) monomers.
- Evaluation of AMOs with different backbone chemistries (phosphorothioate vs. phosphodiester).
- Assessment of the effect of AMO truncation on activity and specificity.
Main Results:
- Incorporation of LNA monomers increased AMO activity but decreased specificity.
- UNA monomers showed the opposite effect, decreasing activity but increasing specificity.
- Phosphorothioate backbones resulted in higher AMO activity compared to phosphodiester backbones.
- Moderate truncation of AMOs enhanced specificity without significant loss of activity.
Conclusions:
- Chemical modifications and truncations significantly influence AMO performance.
- Strategic design choices, balancing activity and specificity, are essential for effective miRNA-targeted therapies.
- These findings provide valuable guidance for the rational design of AMOs for therapeutic applications.
Related Concept Videos
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...